HEADER TRANSFERASE 16-SEP-14 4V0G TITLE JAK3 IN COMPLEX WITH A COVALENT EGFR INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 816-1098; COMPND 5 SYNONYM: JANUS KINASE 3, JAK-3, LEUKOCYTE JANUS KINASE, L-JAK, COMPND 6 JANUS KINASE 3; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: TYROSINE-PROTEIN KINASE JAK3; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 816-1098; COMPND 13 SYNONYM: JANUS KINASE 3, JAK-3, LEUKOCYTE JANUS KINASE, L-JAK, COMPND 14 JANUS KINASE 3; COMPND 15 EC: 2.7.10.2; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE, EGFR MUTANT, T790M EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DEBRECZENI,E.J.HENNESSY,C.CHUAQUINI,S.ASHTON,N.COCLOUGH, AUTHOR 2 D.A.E.CROSS,C.EBERLEIN,L.GINGIPALLI,T.C.M.KLINOWSKA,J.P.ORME,L.SHA, AUTHOR 3 X.WU REVDAT 1 13-JAN-16 4V0G 0 JRNL AUTH E.J.HENNESSY,C.CHUAQUINI,S.ASHTON,N.COCLOUGH,D.A.E.CROSS, JRNL AUTH 2 J.E.DEBRECZENI,C.EBERLEIN,L.GINGIPALLI,T.C.M.KLINOWSKA, JRNL AUTH 3 J.P.ORME,L.SHA,X.WU JRNL TITL UTILISATION OF STRUCTURE BASED DESIGN TO IDENTIFY NOVEL, JRNL TITL 2 IRREVERSIBLE INHIBITORS OF THE EPIDERMAL GROWTH FACTOR JRNL TITL 3 RECEPTOR (EGFR) HARBORING THE GATEKEEPER T790M MUTATION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 73.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 99.62 REMARK 3 NUMBER OF REFLECTIONS : 12552 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.25359 REMARK 3 R VALUE (WORKING SET) : 0.25160 REMARK 3 FREE R VALUE : 0.29465 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.5 REMARK 3 FREE R VALUE TEST SET COUNT : 593 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.000 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.078 REMARK 3 REFLECTION IN BIN (WORKING SET) : 886 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.79 REMARK 3 BIN R VALUE (WORKING SET) : 0.271 REMARK 3 BIN FREE R VALUE SET COUNT : 42 REMARK 3 BIN FREE R VALUE : 0.356 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4318 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 142 REMARK 3 SOLVENT ATOMS : 12 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.730 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.81 REMARK 3 B22 (A**2) : 6.66 REMARK 3 B33 (A**2) : -1.85 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.523 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.440 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 23.402 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.901 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.869 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4343 ; 0.007 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 3934 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5900 ; 0.989 ; 2.004 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9039 ; 0.756 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 538 ; 5.457 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 174 ;36.649 ;22.701 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 676 ;14.394 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;18.251 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 636 ; 0.053 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4826 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 917 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 916 ; 0.208 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3884 ; 0.168 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2099 ; 0.178 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2359 ; 0.081 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 88 ; 0.131 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 16 ; 0.094 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 52 ; 0.154 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.122 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3469 ; 1.340 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1091 ; 0.186 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4316 ; 1.633 ; 3.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1947 ; 2.198 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1584 ; 3.257 ; 6.000 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1 A 907 4 REMARK 3 1 B 1 B 907 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1205 ; 0.26 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1205 ; 0.25 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 908 A 2000 4 REMARK 3 1 B 908 B 2000 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 A (A): 2651 ; 0.30 ; 0.50 REMARK 3 MEDIUM THERMAL 2 A (A**2): 2651 ; 0.26 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 4V0G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-SEP-14. REMARK 100 THE PDBE ID CODE IS EBI-61773. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL (PILATUS 6M) REMARK 200 DETECTOR MANUFACTURER : DECTRIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13200 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.00 REMARK 200 RESOLUTION RANGE LOW (A) : 73.92 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.5 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.0 REMARK 200 R MERGE (I) : 0.14 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.80 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.0 REMARK 200 R MERGE FOR SHELL (I) : 0.44 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.70 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.57000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.68650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.51600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.68650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.57000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.51600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 816 REMARK 465 PRO A 893 REMARK 465 GLY A 894 REMARK 465 GLU A 895 REMARK 465 PRO A 896 REMARK 465 PRO A 986 REMARK 465 GLY A 987 REMARK 465 GLN A 988 REMARK 465 SER A 989 REMARK 465 GLY A 1039 REMARK 465 CYS A 1040 REMARK 465 GLU A 1041 REMARK 465 ARG A 1042 REMARK 465 ASP A 1043 REMARK 465 PRO B 893 REMARK 465 GLY B 894 REMARK 465 GLU B 895 REMARK 465 PRO B 896 REMARK 465 GLU B 985 REMARK 465 PRO B 986 REMARK 465 GLY B 987 REMARK 465 GLN B 988 REMARK 465 SER B 989 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 819 CG CD OE1 OE2 REMARK 470 LYS A 823 CE NZ REMARK 470 GLN A 827 OE1 NE2 REMARK 470 LYS A 830 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 819 CG CD OE1 OE2 REMARK 480 LYS A 823 CE NZ REMARK 480 ILE A 825 CD1 REMARK 480 GLN A 827 OE1 NE2 REMARK 480 LYS A 830 CG CD CE NZ REMARK 480 ASN A 832 CG OD1 ND2 REMARK 480 PHE A 833 CG CD1 CD2 CE1 CE2 CZ REMARK 480 ASP A 846 CG OD1 OD2 REMARK 480 THR A 848 OG1 CG2 REMARK 480 LYS A 855 NZ REMARK 480 GLN A 856 CD OE1 NE2 REMARK 480 LEU A 857 CD1 CD2 REMARK 480 GLN A 858 CG CD OE1 NE2 REMARK 480 SER A 860 OG REMARK 480 ASP A 863 OD1 OD2 REMARK 480 ARG A 866 CD NE CZ NH1 NH2 REMARK 480 LYS A 885 CE NZ REMARK 480 LEU A 898 CD1 CD2 REMARK 480 ARG A 899 NE CZ NH1 NH2 REMARK 480 ARG A 916 NE CZ NH1 NH2 REMARK 480 ARG A 920 CD NE CZ NH1 NH2 REMARK 480 LYS A 972 NZ REMARK 480 ASP A 977 CG OD1 OD2 REMARK 480 ARG A 984 CG CD NE CZ NH1 NH2 REMARK 480 GLU A 985 CG CD OE1 OE2 REMARK 480 ILE A 991 CG1 CG2 CD1 REMARK 480 ASN A 1002 CG OD1 ND2 REMARK 480 ILE A 1003 CD1 REMARK 480 LYS A 1026 CE NZ REMARK 480 PHE A 1034 CG CD1 CD2 CE1 CE2 CZ REMARK 480 LEU A 1035 CD1 CD2 REMARK 480 ARG A 1036 CG CD NE CZ NH1 NH2 REMARK 480 MET A 1037 CG SD CE REMARK 480 LEU A 1047 CD1 CD2 REMARK 480 SER A 1048 OG REMARK 480 ARG A 1049 NE CZ NH1 NH2 REMARK 480 LEU A 1050 CG CD1 CD2 REMARK 480 GLU A 1052 CG CD OE1 OE2 REMARK 480 GLU A 1072 OE1 OE2 REMARK 480 LYS A 1075 NZ REMARK 480 LEU A 1076 CD1 CD2 REMARK 480 GLN A 1083 CG CD OE1 NE2 REMARK 480 ILE B 816 CG1 CG2 CD1 REMARK 480 GLU B 818 CG CD OE1 OE2 REMARK 480 GLU B 819 CD OE1 OE2 REMARK 480 ARG B 820 NE CZ NH1 NH2 REMARK 480 LYS B 823 NZ REMARK 480 LYS B 830 CG CD CE NZ REMARK 480 ASN B 832 CG OD1 ND2 REMARK 480 PHE B 833 CG CD1 CD2 CE1 CE2 CZ REMARK 480 ASP B 846 CG OD1 OD2 REMARK 480 THR B 848 OG1 CG2 REMARK 480 GLN B 856 CG CD OE1 NE2 REMARK 480 GLN B 858 CD OE1 NE2 REMARK 480 SER B 860 OG REMARK 480 GLN B 864 OE1 NE2 REMARK 480 GLN B 865 CG CD OE1 NE2 REMARK 480 ARG B 870 CG CD NE CZ NH1 NH2 REMARK 480 LYS B 876 NZ REMARK 480 LYS B 885 CE NZ REMARK 480 ARG B 899 CZ NH1 NH2 REMARK 480 ARG B 916 CD NE CZ NH1 NH2 REMARK 480 LYS B 935 CE NZ REMARK 480 LYS B 972 NZ REMARK 480 ASP B 977 CG OD1 OD2 REMARK 480 LYS B 978 CE NZ REMARK 480 ARG B 984 CG CD NE CZ NH1 NH2 REMARK 480 ILE B 991 CD1 REMARK 480 LYS B 1026 NZ REMARK 480 SER B 1048 OG REMARK 480 GLU B 1056 CD OE1 OE2 REMARK 480 LYS B 1075 NZ REMARK 480 GLN B 1083 OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A1072 CD GLU A1072 OE1 -0.072 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 822 79.83 -69.77 REMARK 500 ASN A 847 29.96 43.12 REMARK 500 GLN A 858 -87.12 -81.50 REMARK 500 ASP A 881 3.15 -67.91 REMARK 500 TYR A 891 72.39 52.43 REMARK 500 ASP A 949 46.68 -157.46 REMARK 500 ASP A 967 85.88 39.25 REMARK 500 CYS A1028 30.25 -99.82 REMARK 500 GLU B 818 107.92 -52.60 REMARK 500 GLU B 819 -57.47 -24.56 REMARK 500 LEU B 822 88.04 -65.36 REMARK 500 ASP B 842 79.49 -117.11 REMARK 500 GLN B 858 -86.55 -82.93 REMARK 500 ASP B 881 0.72 -67.68 REMARK 500 TYR B 891 61.88 61.61 REMARK 500 ARG B 948 -17.09 67.95 REMARK 500 ASP B 949 52.96 -144.41 REMARK 500 ASP B 967 76.68 52.03 REMARK 500 PHE B 968 37.57 -96.09 REMARK 500 SER B1040 45.32 33.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 G9B A 2099 REMARK 615 G9B B 2099 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G9B A2099 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G9B B2099 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUES REMARK 800 PTR B 980 AND PTR B 981 DBREF 4V0G A 816 1098 UNP P52333 JAK3_HUMAN 816 1098 DBREF 4V0G B 816 1098 UNP P52333 JAK3_HUMAN 816 1098 SEQADV 4V0G GLU A 895 UNP P52333 ARG 895 CONFLICT SEQADV 4V0G PRO A 896 UNP P52333 GLN 896 CONFLICT SEQADV 4V0G SER A 1048 UNP P52333 CYS 1048 CONFLICT SEQADV 4V0G GLY B 894 UNP P52333 ARG 895 CONFLICT SEQADV 4V0G GLU B 895 UNP P52333 GLN 896 CONFLICT SEQADV 4V0G GLY B 1039 UNP P52333 CYS 1040 CONFLICT SEQADV 4V0G SER B 1048 UNP P52333 CYS 1048 CONFLICT SEQRES 1 A 283 ILE PHE GLU GLU ARG HIS LEU LYS TYR ILE SER GLN LEU SEQRES 2 A 283 GLY LYS GLY ASN PHE GLY SER VAL GLU LEU CYS ARG TYR SEQRES 3 A 283 ASP PRO LEU GLY ASP ASN THR GLY ALA LEU VAL ALA VAL SEQRES 4 A 283 LYS GLN LEU GLN HIS SER GLY PRO ASP GLN GLN ARG ASP SEQRES 5 A 283 PHE GLN ARG GLU ILE GLN ILE LEU LYS ALA LEU HIS SER SEQRES 6 A 283 ASP PHE ILE VAL LYS TYR ARG GLY VAL SER TYR GLY PRO SEQRES 7 A 283 GLY GLU PRO SER LEU ARG LEU VAL MET GLU TYR LEU PRO SEQRES 8 A 283 SER GLY CYS LEU ARG ASP PHE LEU GLN ARG HIS ARG ALA SEQRES 9 A 283 ARG LEU ASP ALA SER ARG LEU LEU LEU TYR SER SER GLN SEQRES 10 A 283 ILE CYS LYS GLY MET GLU TYR LEU GLY SER ARG ARG CYS SEQRES 11 A 283 VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU VAL GLU SEQRES 12 A 283 SER GLU ALA HIS VAL LYS ILE ALA ASP PHE GLY LEU ALA SEQRES 13 A 283 LYS LEU LEU PRO LEU ASP LYS ASP PTR PTR VAL VAL ARG SEQRES 14 A 283 GLU PRO GLY GLN SER PRO ILE PHE TRP TYR ALA PRO GLU SEQRES 15 A 283 SER LEU SER ASP ASN ILE PHE SER ARG GLN SER ASP VAL SEQRES 16 A 283 TRP SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR TYR SEQRES 17 A 283 CYS ASP LYS SER CYS SER PRO SER ALA GLU PHE LEU ARG SEQRES 18 A 283 MET MET GLY CYS GLU ARG ASP VAL PRO ALA LEU SER ARG SEQRES 19 A 283 LEU LEU GLU LEU LEU GLU GLU GLY GLN ARG LEU PRO ALA SEQRES 20 A 283 PRO PRO ALA CYS PRO ALA GLU VAL HIS GLU LEU MET LYS SEQRES 21 A 283 LEU CYS TRP ALA PRO SER PRO GLN ASP ARG PRO SER PHE SEQRES 22 A 283 SER ALA LEU GLY PRO GLN LEU ASP MET LEU SEQRES 1 B 283 ILE PHE GLU GLU ARG HIS LEU LYS TYR ILE SER GLN LEU SEQRES 2 B 283 GLY LYS GLY ASN PHE GLY SER VAL GLU LEU CYS ARG TYR SEQRES 3 B 283 ASP PRO LEU GLY ASP ASN THR GLY ALA LEU VAL ALA VAL SEQRES 4 B 283 LYS GLN LEU GLN HIS SER GLY PRO ASP GLN GLN ARG ASP SEQRES 5 B 283 PHE GLN ARG GLU ILE GLN ILE LEU LYS ALA LEU HIS SER SEQRES 6 B 283 ASP PHE ILE VAL LYS TYR ARG GLY VAL SER TYR GLY PRO SEQRES 7 B 283 GLY GLU PRO SER LEU ARG LEU VAL MET GLU TYR LEU PRO SEQRES 8 B 283 SER GLY CYS LEU ARG ASP PHE LEU GLN ARG HIS ARG ALA SEQRES 9 B 283 ARG LEU ASP ALA SER ARG LEU LEU LEU TYR SER SER GLN SEQRES 10 B 283 ILE CYS LYS GLY MET GLU TYR LEU GLY SER ARG ARG CYS SEQRES 11 B 283 VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU VAL GLU SEQRES 12 B 283 SER GLU ALA HIS VAL LYS ILE ALA ASP PHE GLY LEU ALA SEQRES 13 B 283 LYS LEU LEU PRO LEU ASP LYS ASP PTR PTR VAL VAL ARG SEQRES 14 B 283 GLU PRO GLY GLN SER PRO ILE PHE TRP TYR ALA PRO GLU SEQRES 15 B 283 SER LEU SER ASP ASN ILE PHE SER ARG GLN SER ASP VAL SEQRES 16 B 283 TRP SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR TYR SEQRES 17 B 283 CYS ASP LYS SER CYS SER PRO SER ALA GLU PHE LEU ARG SEQRES 18 B 283 MET MET GLY SER GLU ARG ASP VAL PRO ALA LEU SER ARG SEQRES 19 B 283 LEU LEU GLU LEU LEU GLU GLU GLY GLN ARG LEU PRO ALA SEQRES 20 B 283 PRO PRO ALA CYS PRO ALA GLU VAL HIS GLU LEU MET LYS SEQRES 21 B 283 LEU CYS TRP ALA PRO SER PRO GLN ASP ARG PRO SER PHE SEQRES 22 B 283 SER ALA LEU GLY PRO GLN LEU ASP MET LEU MODRES 4V0G PTR A 980 TYR O-PHOSPHOTYROSINE MODRES 4V0G PTR A 981 TYR O-PHOSPHOTYROSINE MODRES 4V0G PTR B 980 TYR O-PHOSPHOTYROSINE MODRES 4V0G PTR B 981 TYR O-PHOSPHOTYROSINE HET PTR A 980 16 HET PTR A 981 16 HET PTR B 980 16 HET PTR B 981 16 HET G9B A2099 39 HET G9B B2099 39 HETNAM G9B N-[3-(2-{3-AMINO-6-[1-(1-METHYLPIPERIDIN-4- HETNAM 2 G9B YL)-1H-PYRAZOL-4-YL]PYRAZIN-2-YL}-1H- HETNAM 3 G9B BENZIMIDAZOL-1-YL)PHENYL]PROPANAMIDE HETNAM PTR O-PHOSPHOTYROSINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 3 G9B 2(C29 H31 N9 O) FORMUL 4 PTR 4(C9 H12 N O6 P) FORMUL 5 HOH *12(H2 O) HELIX 1 1 GLU A 818 ARG A 820 5 3 HELIX 2 2 GLY A 861 LEU A 878 1 18 HELIX 3 3 CYS A 909 HIS A 917 1 9 HELIX 4 4 ASP A 922 ARG A 943 1 22 HELIX 5 5 ALA A 951 ARG A 953 5 3 HELIX 6 6 PRO A 990 TYR A 994 5 5 HELIX 7 7 ALA A 995 ASN A 1002 1 8 HELIX 8 8 ARG A 1006 THR A 1022 1 17 HELIX 9 9 SER A 1029 MET A 1037 1 9 HELIX 10 10 PRO A 1045 GLU A 1056 1 12 HELIX 11 11 PRO A 1067 TRP A 1078 1 12 HELIX 12 12 SER A 1081 ARG A 1085 5 5 HELIX 13 13 SER A 1087 MET A 1097 1 11 HELIX 14 14 GLU B 818 ARG B 820 5 3 HELIX 15 15 GLY B 861 LEU B 878 1 18 HELIX 16 16 CYS B 909 HIS B 917 1 9 HELIX 17 17 ASP B 922 ARG B 943 1 22 HELIX 18 18 ALA B 951 ARG B 953 5 3 HELIX 19 19 PRO B 990 TYR B 994 5 5 HELIX 20 20 ALA B 995 ASP B 1001 1 7 HELIX 21 21 ARG B 1006 THR B 1022 1 17 HELIX 22 22 SER B 1029 MET B 1038 1 10 HELIX 23 23 PRO B 1045 GLU B 1056 1 12 HELIX 24 24 PRO B 1067 TRP B 1078 1 12 HELIX 25 25 SER B 1081 ARG B 1085 5 5 HELIX 26 26 SER B 1087 MET B 1097 1 11 SHEET 1 AA 5 LEU A 822 LYS A 830 0 SHEET 2 AA 5 GLY A 834 TYR A 841 -1 O VAL A 836 N LEU A 828 SHEET 3 AA 5 ALA A 850 LEU A 857 -1 O ALA A 850 N TYR A 841 SHEET 4 AA 5 ARG A 899 GLU A 903 -1 O LEU A 900 N LYS A 855 SHEET 5 AA 5 TYR A 886 SER A 890 -1 N ARG A 887 O VAL A 901 SHEET 1 AB 2 CYS A 945 VAL A 946 0 SHEET 2 AB 2 LYS A 972 LEU A 973 -1 O LYS A 972 N VAL A 946 SHEET 1 AC 2 ILE A 955 SER A 959 0 SHEET 2 AC 2 HIS A 962 ILE A 965 -1 O HIS A 962 N GLU A 958 SHEET 1 AD 2 PTR A 980 VAL A 982 0 SHEET 2 AD 2 ILE A1003 SER A1005 -1 O PHE A1004 N PTR A 981 SHEET 1 BA 5 LEU B 822 GLY B 829 0 SHEET 2 BA 5 VAL B 836 TYR B 841 -1 O VAL B 836 N LEU B 828 SHEET 3 BA 5 ALA B 850 LYS B 855 -1 O ALA B 850 N TYR B 841 SHEET 4 BA 5 ARG B 899 GLU B 903 -1 O LEU B 900 N LYS B 855 SHEET 5 BA 5 TYR B 886 SER B 890 -1 N ARG B 887 O VAL B 901 SHEET 1 BB 2 CYS B 945 VAL B 946 0 SHEET 2 BB 2 LYS B 972 LEU B 973 -1 O LYS B 972 N VAL B 946 SHEET 1 BC 2 ILE B 955 VAL B 957 0 SHEET 2 BC 2 VAL B 963 ILE B 965 -1 O LYS B 964 N LEU B 956 SHEET 1 BD 2 PTR B 980 VAL B 982 0 SHEET 2 BD 2 ILE B1003 SER B1005 -1 O PHE B1004 N PTR B 981 LINK SG CYS A 909 C20 G9B A2099 1555 1555 1.74 LINK C ASP A 979 N PTR A 980 1555 1555 1.33 LINK C PTR A 980 N PTR A 981 1555 1555 1.33 LINK C PTR A 981 N VAL A 982 1555 1555 1.33 LINK SG CYS B 909 C20 G9B B2099 1555 1555 1.73 LINK C ASP B 979 N PTR B 980 1555 1555 1.33 LINK C PTR B 980 N PTR B 981 1555 1555 1.33 LINK C PTR B 981 N VAL B 982 1555 1555 1.33 SITE 1 AC1 12 LEU A 828 ALA A 853 MET A 902 GLU A 903 SITE 2 AC1 12 TYR A 904 LEU A 905 PRO A 906 GLY A 908 SITE 3 AC1 12 CYS A 909 ASP A 912 ARG A 953 ASP A 967 SITE 1 AC2 10 ALA B 853 MET B 902 GLU B 903 TYR B 904 SITE 2 AC2 10 LEU B 905 PRO B 906 GLY B 908 CYS B 909 SITE 3 AC2 10 ASP B 912 ASP B 967 SITE 1 AC3 10 ARG A 870 LYS A 972 LEU A 973 PRO A 975 SITE 2 AC3 10 LYS A 978 ASP A 979 VAL A 982 VAL A 983 SITE 3 AC3 10 ILE A1003 PHE A1004 SITE 1 AC4 8 LYS B 972 LEU B 973 PRO B 975 LYS B 978 SITE 2 AC4 8 ASP B 979 VAL B 982 ILE B1003 PHE B1004 CRYST1 57.140 99.032 111.373 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017501 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010098 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008979 0.00000